The U.S. may be further into Delta surge than it appears

Just how far along into the latest Delta variant-fueled coronavirus surge is the United States? No one knows for sure, but former Food and Drug Administration Commissioner Scott Gottlieb is hopeful the country can "turn a corner" in just two or three weeks, he told CBS News' John Dickerson on Sunday's edition of Face the Nation.
There's a couple of reasons behind the relatively optimistic outlook. For starters, Gottlieb, who has criticized the Centers for Disease Control and Prevention's wide-ranging forecasts for the current wave, believes it's likely there are a lot of mild or subclinical infections in the U.S., which means the number of cases picked up by testing is probably an underestimate of the virus' actual spread. He's also looking across the pond to the United Kingdom, where cases appear to be trending downward again after rising for several weeks. The U.K., Gottlieb noted, has been a few weeks ahead of the U.S. so far and could serve as a sneak preview of the national trajectory.
FiveThirtyEight's Nate Silver also thinks it's worth paying attention to the U.K., as well as India, where the Delta variant originated. Their most recent waves were big ones, but they did appear to turn around quite quickly.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Of course, the U.K. needs to show that it can sustain its recent drop, and either way, the U.S. will likely have a less cohesive path out of the latest wave given the disparate vaccination rates across the country.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
What to know before turning to AI for financial advice
the explainer It can help you crunch the numbers — but it might also pocket your data
-
Book reviews: 'The Headache: The Science of a Most Confounding Affliction—and a Search for Relief' and 'Tonight in Jungleland: The Making of Born to Run'
Feature The search for a headache cure and revisiting Springsteen's 'Born to Run' album on its 50th anniversary
-
Keith McNally' 6 favorite books that have ambitious characters
Feature The London-born restaurateur recommends works by Leo Tolstoy, John le Carré, and more
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC